These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2933535)

  • 1. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy.
    Redfield RR; Innis BL; Scott RM; Cannon HG; Bancroft WH
    JAMA; 1985 Dec; 254(22):3203-6. PubMed ID: 2933535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
    Frazer IH; Jones B; Dimitrakakis M; Mackay IR
    Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal vaccination against hepatitis B in Immanuel Hospital personnel--a preliminary report.
    Prasetya E; Linggadjaja W; Syambali R; Kusumo S; Dharmesetyawan DF; Rahardja U
    Ann Acad Med Singap; 1986 Apr; 15(2):153-7. PubMed ID: 2944466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the immunogenicity of hepatitis B vaccine administered intradermally and intramuscularly.
    King JW; Taylor EM; Crow SD; White MC; Todd JR; Poe MB; Conrad SA; Gelder FB
    Rev Infect Dis; 1990; 12(6):1035-43. PubMed ID: 2148433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and side effects of low dose intradermally administered hepatitis B vaccine.
    Pathak UN; Dilawari JB; Chawla Y; Sokhey CS; Sharma BK; Ganguly NK
    Indian J Gastroenterol; 1988 Apr; 7(2):113-4. PubMed ID: 2966113
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost effectiveness of intradermal vs. subcutaneous hepatitis B vaccination for the mentally handicapped.
    Hayashi J; Nakashima K; Noguchi A; Morofuji M; Kashiwagi S
    J Infect; 1991 Jul; 23(1):39-45. PubMed ID: 1832182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intradermal inoculation with Heptavax-B. Immune response and histologic evaluation of injection sites.
    Clarke JA; Hollinger FB; Lewis E; Russell LA; Miller CH; Huntley A; Flynn NM
    JAMA; 1989 Nov; 262(18):2567-71. PubMed ID: 2530364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative trial of low-dose, intradermal, recombinant- and plasma-derived hepatitis B vaccines.
    Bryan JP; Sjogren M; Iqbal M; Khattak AR; Nabi S; Ahmed A; Cox B; Morton A; Shuck J; Macarthy P
    J Infect Dis; 1990 Oct; 162(4):789-93. PubMed ID: 2144866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenicity and safety of intradermal hepatitis B vaccine.
    Toffler WL; Olenick JS; Wolf NE; Retzlaff ZH; Swanson JR; Kenny TA
    J Fam Pract; 1991 Aug; 33(2):149-54. PubMed ID: 1832438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of intradermal hepatitis B immunization of hospital staff.
    McKee CM; Duke P; McEvoy MB; Kelsey MC
    Int J STD AIDS; 1990 Jan; 1(1):32-4. PubMed ID: 2151564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal hepatitis B vaccination in an abbreviated schedule.
    Halsey NA; Reppert EJ; Margolis HS; Francis DP; Fields HA
    Vaccine; 1986 Dec; 4(4):228-32. PubMed ID: 3541426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal and intramuscular route for vaccination against hepatitis B.
    González ML; Usandizaga M; Alomar P; Salvá F; Martín F; Erroz MJ; Lardinois R
    Vaccine; 1990 Aug; 8(4):402-5. PubMed ID: 2144391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose intradermal and intramuscular vaccination against hepatitis B.
    Bryan JP; Sjogren MH; Perine PL; Legters LJ
    Clin Infect Dis; 1992 Mar; 14(3):697-707. PubMed ID: 1532914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal hepatitis B vaccine in thalassaemia and sickle cell disease.
    Mok Q; Underhill G; Wonke B; Aldouri M; Kelsey M; Jefferies D
    Arch Dis Child; 1989 Apr; 64(4):535-40. PubMed ID: 2526622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intradermal, subcutaneous or intramuscular administration of hepatitis B vaccine: side effects and antibody response.
    Wahl M; Hermodsson S
    Scand J Infect Dis; 1987; 19(6):617-21. PubMed ID: 3441747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial.
    Launay O; van der Vliet D; Rosenberg AR; Michel ML; Piroth L; Rey D; Colin de Verdière N; Slama L; Martin K; Lortholary O; Carrat F;
    JAMA; 2011 Apr; 305(14):1432-40. PubMed ID: 21486976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of an anti-hepatitis-B vaccination in a population at risk].
    Stellato M; Carbi S; Tosolini S
    Boll Ist Sieroter Milan; 1989; 68(1):34-41. PubMed ID: 2535244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose hepatitis B vaccination in children.
    Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S
    N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.
    Parish DC; Muecke HW; Joiner TA; Pope WT; Hadler SC
    South Med J; 1991 Apr; 84(4):426-30. PubMed ID: 1826567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.